PortfoliosLab logoPortfoliosLab logo
PM vs. NVS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PM vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Philip Morris International Inc. (PM) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PM achieves a 15.93% return, which is significantly higher than NVS's 14.40% return. Both investments have delivered pretty close results over the past 10 years, with PM having a 11.71% annualized return and NVS not far behind at 11.14%.


PM

1D
1.95%
1M
-1.92%
YTD
15.93%
6M
22.12%
1Y
3.66%
3Y*
31.18%
5Y*
18.78%
10Y*
11.71%

NVS

1D
-0.55%
1M
2.22%
YTD
14.40%
6M
18.98%
1Y
30.60%
3Y*
19.57%
5Y*
14.77%
10Y*
11.14%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PM vs. NVS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PM
Philip Morris International Inc.
15.93%37.99%34.34%-1.85%12.31%20.78%3.69%35.02%-33.30%19.85%
NVS
Novartis AG
14.40%46.95%0.02%16.14%8.06%-3.65%3.34%13.92%5.95%19.42%

Correlation

The correlation between PM and NVS is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.23

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.31

Correlation (10Y)
Calculated over the trailing 10-year period

0.30

Correlation (All Time)
Calculated using the full available price history since Mar 17, 2008

0.35

The correlation between PM and NVS shifts across timeframes, from 0.23 (1 year) to 0.35 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

PM:

$288.03B

NVS:

$293.28B

EPS

PM:

$7.12

NVS:

$6.99

PE Ratio

PM:

25.90

NVS:

21.90

PEG Ratio

PM:

2.81

NVS:

1.48

PS Ratio

PM:

6.93

NVS:

5.29

Total Revenue (TTM)

PM:

$41.49B

NVS:

$56.05B

Gross Profit (TTM)

PM:

$27.93B

NVS:

$42.19B

EBITDA (TTM)

PM:

$17.74B

NVS:

$22.40B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PM vs. NVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PM
PM Risk / Return Rank: 4444
Overall Rank
PM Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
PM Sortino Ratio Rank: 4141
Sortino Ratio Rank
PM Omega Ratio Rank: 4141
Omega Ratio Rank
PM Calmar Ratio Rank: 4747
Calmar Ratio Rank
PM Martin Ratio Rank: 4747
Martin Ratio Rank

NVS
NVS Risk / Return Rank: 8080
Overall Rank
NVS Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
NVS Sortino Ratio Rank: 7979
Sortino Ratio Rank
NVS Omega Ratio Rank: 7777
Omega Ratio Rank
NVS Calmar Ratio Rank: 8080
Calmar Ratio Rank
NVS Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PM vs. NVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Philip Morris International Inc. (PM) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PMNVSDifference
Sharpe ratioReturn per unit of total volatility

-1.34

Sortino ratioReturn per unit of downside risk

-1.73

Omega ratioGain probability vs. loss probability

1.05

1.26

-0.21

Calmar ratioReturn relative to maximum drawdown

0.18

2.43

-2.25

Martin ratioReturn relative to average drawdown

0.34

5.88

-5.54

PM vs. NVS - Sharpe Ratio Comparison

The current PM Sharpe Ratio is 0.13, which is lower than the NVS Sharpe Ratio of 1.47. The chart below compares the historical Sharpe Ratios of PM and NVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PM vs. NVS - Drawdown Comparison

The maximum PM drawdown since its inception was -42.87%, roughly equal to the maximum NVS drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for PM and NVS.


Loading charts...

Drawdown Indicators


PMNVSDifference

Max Drawdown

Largest peak-to-trough decline

-42.87%

-42.10%

-0.77%

Max Drawdown (1Y)

Largest decline over 1 year

-20.64%

-12.65%

-7.99%

Max Drawdown (3Y)

Largest decline over 3 years

-20.64%

-19.95%

-0.69%

Max Drawdown (5Y)

Largest decline over 5 years

-22.78%

-20.42%

-2.36%

Max Drawdown (10Y)

Largest decline over 10 years

-42.87%

-26.03%

-16.84%

Current Drawdown

Current decline from peak

-3.94%

-6.46%

+2.52%

Average Drawdown

Average peak-to-trough decline

-10.02%

-10.92%

+0.90%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.81%

5.23%

+5.58%

Volatility

PM vs. NVS - Volatility Comparison

Philip Morris International Inc. (PM) has a higher volatility of 7.76% compared to Novartis AG (NVS) at 7.18%. This indicates that PM's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PMNVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.76%

7.18%

+0.58%

Volatility (6M)

Calculated over the trailing 6-month period

21.07%

14.96%

+6.11%

Volatility (1Y)

Calculated over the trailing 1-year period

27.73%

21.02%

+6.71%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.73%

18.89%

+3.84%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.46%

19.64%

+4.82%

Dividends

PM vs. NVS - Dividend Comparison

PM's dividend yield for the trailing twelve months is around 3.13%, which matches NVS's 3.12% yield.


PositionTTM20252024202320222021202020192018201720162015
NVS
Novartis AG
3.12%2.90%3.84%3.44%3.70%3.86%3.22%3.03%3.47%3.24%3.73%3.10%
PM
Philip Morris International Inc.
3.13%3.52%4.40%5.46%4.98%5.16%5.73%5.43%6.73%3.99%4.50%4.60%

Financials

PM vs. NVS - Financials Comparison

This section allows you to compare key financial metrics between Philip Morris International Inc. and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


8.00B10.00B12.00B14.00B20222023202420252026
10.15B
13.52B
(PM) Total Revenue
(NVS) Total Revenue
Values in USD except per share items

PM vs. NVS - Profitability Comparison

The chart below illustrates the profitability comparison between Philip Morris International Inc. and Novartis AG over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

65.0%70.0%75.0%20222023202420252026
68.1%
74.4%
Portfolio components
PM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Philip Morris International Inc. reported a gross profit of 6.91B and revenue of 10.15B. Therefore, the gross margin over that period was 68.1%.

NVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a gross profit of 10.07B and revenue of 13.52B. Therefore, the gross margin over that period was 74.4%.

PM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Philip Morris International Inc. reported an operating income of 3.89B and revenue of 10.15B, resulting in an operating margin of 38.4%.

NVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported an operating income of 4.24B and revenue of 13.52B, resulting in an operating margin of 31.3%.

PM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Philip Morris International Inc. reported a net income of 2.44B and revenue of 10.15B, resulting in a net margin of 24.0%.

NVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a net income of 3.16B and revenue of 13.52B, resulting in a net margin of 23.3%.


Frequently Asked Questions


PM and NVS have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PM has higher volatility (7.76%) compared to NVS (7.18%). In terms of maximum drawdown, PM dropped -42.87% vs NVS's -42.10%.

NVS currently has the higher Sharpe Ratio (1.47 vs 0.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PM and NVS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer